Stereotaxis Introduces Respiratory Compensation Feature for Remote Magnetic Navigation Procedures
October 12, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the worldwide...
Stereotaxis Announces Results of Warrants Offering
October 08, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 08, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (“Stereotaxis”) (NASDAQ:STXS) a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced...
Stereotaxis Extends Warrants Offering Subscription Period
September 28, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced it is extending its...
Stereotaxis Launches Vmotion Suite of Automation Features in U.S. Following FDA Clearance
September 23, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the first procedures...
U.S. Physician Surpasses 1,000 Procedures Using Stereotaxis Niobe(R) System
September 21, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that J. David...
Stereotaxis Announces Ex-Warrants Date of September 15, 2015 for Warrants Offering
September 15, 2015 07:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that the NASDAQ...
Stereotaxis Announces Warrants Offering
September 04, 2015 07:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will conduct...
Stereotaxis Awarded U.S. Patent Covering Transmission of Data for Odyssey(R) Solutions
September 01, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Patent...
Westmead Hospital Research Provides Significant Data Supporting the Ablation Effectiveness of Stereotaxis Magnetic Navigation
August 27, 2015 07:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 27, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS) and Westmead Hospital in Australia today announced findings of a recent study comparing the stability of a Niobe®...
Erasmus Medical Center Study Highlights Advantages of Stereotaxis Platform Compared to State-of-the-Art Manual Techniques in VT
August 10, 2015 07:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS) and Erasmus Medical Center in Rotterdam, The Netherlands today announced the results of a seven-year clinical study, which...